Safety
Why the pregnancy rule around DHT-blockers exists, and the line we will not bend.
LoveMyLife clinical team
MRCGP-led
25 May 2026
5 min read

Of all the safety points around hair-loss treatment, the pregnancy one is the firmest. Finasteride and dutasteride can interfere with the normal development of a male baby, which is why there are clear rules about who can take them and how they should be handled.
This article explains the risk plainly and the rule we apply because of it.
Finasteride and dutasteride work by lowering DHT. DHT is essential for the normal development of the external genitalia of a male fetus during pregnancy. If a developing male baby is exposed to these drugs, there is a risk of abnormal genital development.
Because of this, the medicines are classed as teratogenic, meaning capable of causing birth defects, and the precautions follow directly from that fact rather than from any general caution.
We do not prescribe finasteride or dutasteride to women who are pregnant, breastfeeding, or planning pregnancy within the next twelve months. This is a firm line, not a case-by-case judgement.
Dutasteride matters especially here because it stays in the body for a long time after the last dose, so a meaningful washout period is needed before pregnancy would be safe. For women of childbearing potential who do use an oral DHT-blocker in selected off-label situations, reliable contraception and individual counselling are conditions of treatment. For most women, topical minoxidil is the mainstay precisely because it sidesteps this problem, though it too is paused in pregnancy and breastfeeding.
There is a practical point that applies in any household. The risk to a pregnancy comes from the drug getting into the body, so women who are or may become pregnant should not handle crushed or broken finasteride or dutasteride tablets, because the active drug can be absorbed through the skin. Intact, coated tablets are designed to prevent this, so the precaution is specifically about broken or crushed ones. Keeping tablets in their packaging and out of reach of others is sensible.
If you are a man taking finasteride and you and your partner are trying to conceive, the picture is reassuring but worth a conversation. The amount of drug that reaches semen is very small, and the evidence does not show harm to a pregnancy from a man taking finasteride.
Separately, finasteride can in a small number of men reduce sperm count or semen quality, which reverses after stopping. For that reason, men who are actively trying for a baby and are concerned may choose to pause treatment, and it is a reasonable thing to raise at the assessment so the decision is yours and informed.
The twelve-month rule is not meant to close the door on treatment forever, it is about timing. If you may want to conceive in the future but not in the next year, topical minoxidil is the option that keeps treatment on the table now, since it does not carry the same risk, and it is simply paused if and when you become pregnant.
This is one of the main reasons the assessment asks about your plans rather than treating it as a private matter. The question shapes which treatments are safe to offer, and being able to talk about it openly means you get a plan that fits where you are in life rather than a blanket no.
Finasteride and dutasteride can harm a developing male baby, so they are not prescribed to women who are pregnant, breastfeeding or planning pregnancy within twelve months, and broken tablets should not be handled by anyone who may be pregnant. For men, the risk to a partner's pregnancy is very low, with sperm quality the more relevant point to discuss. A short assessment with one of our doctors will make sure the plan fits your circumstances.
Clinically reviewed
Dr Seth Rankin · MBChB MRCGP - Founder and Medical Director, LoveMyLife

The real numbers, and the unsettled question we take seriously.

How the DHT-blocking tablets work, and how they differ.

Using treatments together, and what suits female pattern hair loss.

Doctor-prescribed treatment for men and women.

The full set of hair-loss articles in one place.

Low testosterone, the assessment, and TRT explained.

Hair and other changes are common in perimenopause.

See a doctor in person at Westfield London.

Browse every article we have published.
If you want to move from reading to acting, the next step is a short, confidential assessment with one of our doctors.
Begin your assessment at this link. Online or in person at Westfield London.